Slate Medicines is a Biotech company based in Raleigh, North Carolina. It has raised $130M in total funding. Latest round: Series A.
Slate Medicines is a Biotech company based in Raleigh, North Carolina. Slate Medicines has raised $130M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in February 2025. The round record for Slate Medicines runs through 2025; nothing later has been disclosed. Investors on record include RA Capital Management, Forbion, Foresite Capital. 3 distinct backers are named across the disclosed rounds.
We update the Slate Medicines record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Raleigh and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026